GB2253200A — Inhalation apparatus and fracturable capsule for use therewith
Assigned to Norton Healthcare Ltd · Expires 1992-09-02 · 34y expired
What this patent protects
A capsule (2) containing an inhalant medicament is so formed as to be readily fracturable to release the medicament into the air stream of an inhaler device. Preferably the capsule has areas of reduced cross section, but may be merely formed from readily crushable or fracturable …
USPTO Abstract
A capsule (2) containing an inhalant medicament is so formed as to be readily fracturable to release the medicament into the air stream of an inhaler device. Preferably the capsule has areas of reduced cross section, but may be merely formed from readily crushable or fracturable material. The inhaler comprises a body having a mesh grid (48) on which the capsule sits, and part of the body (34) is movable with respect to the capsule in order to apply pressure to it and fracture it, using grid (50). A further grid (52) between the capsule and a mouth piece ensures that only the medicament exits through the mouth piece into the patient's airways. <IMAGE>
Drugs covered by this patent
- Remodulin (TREPROSTINIL) · United Therap
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.